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ABSTRACT
ELECTRICAL CHARACTERIZATION OF BLOOD CLOTS
by William McGrath
This work reports the use of dielectric spectroscopy to study blood and blood clots. A
test setup was developed and electrode behavior was characterized with water and salt
solutions. By measuring changes in electrical permittivity, trends differentiating clotting
and non-clotting blood were identified. Non-clotting blood exhibited an increase in
normalized permittivity at high frequencies that is credited to the sedimentation of red
blood cells (RBCs) in static blood samples. Clotting blood was found to show a decrease
in permittivity after some time at high frequencies. This is associated with the aggregation
of red blood cells. Platelet rich plasma (PRP) and RBCs were separated and measured so
their effects on permittivity could be studied in isolation. PRP was found to exhibit no
change in electrical measurements. RBCs in PBS had a muted response compared to that
of whole blood. Measurements were also performed on blood treated with TF, TRAP-6,
ADP and thrombin, where decreased clotting time was observed and corresponded to
earlier drops in normalized permittivity. Different phases of clotting including initiation,
polymerization, and completion were identified and potential diagnostic and clinical
relevance is discussed.
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CHAPTER ONE: INTRODUCTION
Problems with coagulation, either severe bleeding or hypercoagulability, are common
in patients in intensive care. Hemorrhage is the second leading cause of death in major
trauma patients [1]. Strokes are caused when blood clots block blood flow to smaller
blood vessels and were the second leading cause of death globally in 2013 [2]. Patients
with coagulation disorders have been found to have softer clots [3] while younger patients
have been found to have stiffer clots [4]. The ability to determine the properties of a blood
clot would be of great use to physicians treating patients experiencing a stroke.
Detecting deep vein thrombosis (DVT), in which a clot forms in one place in the body
and then ends up congesting an artery elsewhere, requires higher sensitivity than current
coagulation test can reliably provide and the use of mechanical systems relying on
damped oscillation with changes in viscosity have low throughput, making a highly
sensitive test capable of high throughput desirable in the diagnosis of DVT [5].
Conventional coagulation monitoring tests are slow and do not provide a comprehensive
picture of hemostasis. Point-of-care (POC) coagulation monitoring is of increasing
interest to care providers because of its ability to provide low-cost, rapid, and more
complete in vivo information [1].
In a healthy human being, hemostasis is the process of limiting blood loss by sealing a
damaged blood vessel with a blood clot. Thrombosis is the formation of blood clots
within a blood vessel that can lead to blockages of normal blood flow. Normal hemostasis
is begun by exposure of plasma to tissue factor (TF). This is also called the extrinsic
pathway. The intrinsic or contact pathway to coagulation occurs when proteins in plasma
are activated by foreign or artificial surfaces. Thrombosis can result from intrinsic or
extrinsic clotting. Both pathways come to a common end when prothrombin is
transformed into thrombin which activates platelets and polymerizes fibrinogen into fibrin.
[6].

Blood coagulation is a complicated process, but can be divided into three main phases.
Initially clotting factors are released with the various activating factors ultimately
transforming prothrombin into thrombin. Second, the thrombin activates platelets and
fibrinogen begins to transform into fibrin strands. The activated platelets attach to the
fibrin strands forming a mesh which traps RBCs. Finally, the platelets pull on the fibrin
strands causing clot retraction and expelling fluid. [7, 8].
There are several existing technologies that measure the viscoelastic properties of
blood including TEG, ROTEM, and the Sonoclot Analyzer. These devices are similar in
that they all measure the physical deflection of a probe inserted into a sample volume of
blood. A clot’s formation rate, stability, and strength can all be determined along with the
time it takes to clot. These assays are best suited for measuring change in an individual
due to a variety of factors that can affect readings including age, gender, hematocrit level,
time since blood draw, whether blood has been citrated or not, temperature, and the
presence of heparin [9].
Two more commonly used tests to assess hemostasis are the prothrombin time (PT)
which measures the extrinsic and common pathways of the clotting cascade and the
activated partial thromboplastin time (APTT) which measures the intrinsic and common
pathways of the clotting cascade. These tests can also be influenced by hematocrit, citrate
concentration, whether the patient has been fasting, and the amount of time elapsed
between blood draw and testing [10].
Recent research has explored the use of impedance analyzers and dielectric
spectroscopy (DS) to characterize blood clotting time [7, 8, 11, 5, 12]. It has been
observed that electrical impedance changes are correlated with changes in RBC size,
aggregation, and clot formation in whole blood [13, 14]. Microfluidic prototypes have
been developed which can perform analysis on extremely small quantities of blood in the
10 µL range [15, 8].
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1.1

Dielectric Spectroscopy
DS is a nondestructive, label-free test method which measures complex relative

dielectric permittivity across a frequency spectrum [16]. Relative dielectric permittivity is
related to polarization and electric field strength in a sample [17]. When an alternating
current (AC) is applied to a material, charges in the material will feel a force to orient in
the same direction as the electric field. At low frequencies, there is sufficient time for the
material to polarize and the relative permittivity is real and constant (sometimes called the
dielectric constant). At very high frequencies, there is no time for the charges to orient
with the electric field and no polarization. At intermediate frequencies, where the period
of the AC signal is similar to the time it takes for the material to polarize (relaxation time),
the relative permittivity becomes complex. The real part of the relative permittivity
represents the polarization of charge while the imaginary part represents electric energy
lost as heat [18].
Complex relative permittivity is defined as the ratio of the material’s permittivity
((ω)) to vacuum permittivity (0 ). It is also defined as the ratio of the change in
capacitance when the dielectric is changed from a vacuum (C0 , often approximated with
air) to the material in question (C), see Equation 1 below.
r (ω) =

C
(ω)
=
0
C0

Equation 1

The relative dielectric permittivity is calculated from complex impedance
measurements. The complex impedance of a system is measured with an impedance
analyzer which applies a time varying voltage and measures the current response and
phase shift [19]. The complex impedance, Z, is given by the ratio of voltage, V, to current,
I, as shown in Equation 2.
Z=

V (t)
I(t)
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Equation 2

Since complex relative permittivity is a measure of polarization or energy stored, it is
calculated from the imaginary part of complex impedance which represents energy stored.
The imaginary part of complex impedance is related to capacitance, Equation 3, which
can then be used to calculate the complex relative permittivity.
Imag(Z) =

1
jωC

Equation 3

Relating the complex relative dielectric permittivity to physical phenomena requires
analysis of the equivalent circuit which is dependent on the test setup. The measured
response may have parasitic components and even the material under investigation can
have different responses at different frequencies. Two common test setups are discussed,
the parallel plate capacitor (PPC) method and the planar interdigitated electrode (IDE)
method.
1.2

Parallel Plate Capacitor Method
The parallel plate capacitor method uses two parallel electrodes with the material of

interest as the dielectric between them, in this case blood. Suster et al. presented a
thorough analysis of the impedance and equivalent circuit for whole blood in a parallel
plate capacitor setup in [12]. The ionic content in blood forms a capacitive double layer
(CDL) at each electrode interface which was considered in series with the ideal parallel
plate capacitance. The total impedance of their setup was given by Equation 4.
ZP P C =

1
0

00

jωC0 (r,P P C − jr,P P C )

= ZCDL +

1
jωC0 r,B

Equation 4

The term ZP P C is the total complex impedance. The middle form represents what is
measured by the impedance analyzer, where j is the imaginary unit, ω is the angular
frequency of measurement, C0 is the air-gap capacitance of the sensor with no blood
0

00

between the plates, while r,P P C and r,P P C are the real and imaginary parts of the
measured relative dielectric permittivity respectively. On the right the impedance is split
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into ZCDL , the capacitive double layer impedance, and the final term which represents the
ideal parallel plate capacitance of the sensor where r,B is the relative permittivity of
whole blood.
The real and imaginary parts of the relative dielectric permittivity are calculated from
Equation 5 and Equation 6 respectively.
0

r,P P C =

00

imag(ZP−1P P C )
ωC0

Equation 5

real(ZP−1P C )
ωC0

Equation 6

r,P P C =

The equivalent circuit model for whole blood in their parallel plate capacitor setup is
shown in Figure 1. The constant phase element ZCDL represents the capacitive double
layer effect, capacitor CH2 O represents permittivity at high frequencies attributed to water
molecules, resistor Ric models ionic conductivity as dc resistance, and the set of parallel
resistors and capacitors (R1, C1, R2, C2) represent interfacial polarization of red blood
cells (RBCs).

Figure 1. Equivalent circuit model of whole blood in a parallel plate capacitor sensor.
An understanding of the differences between the measured impedance and the
modeled impedance gives insight into how to connect observed electric phenomena with
the physical behavior of blood. Measurement frequency choice is important, as Figure 1
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shows there are multiple paths for current to take. If the desire is to measure blood clotting
time as in [12] then the frequency should be chosen to minimize contributions from the
CDL and allow the majority of the current to pass through R1 − C1 and R2 − C2
branches. When reaching very high frequencies eventually the current will be shorted
through CH2 O and the response will primarily reflect the behavior of water.
1.3

Interdigitated Electrode Method
The IDE method uses two electrodes in the same plane with interleaving fingers

extending from each electrode and solution is deposited on top of the interleaving fingers.
Rana et al. provides an analysis of this electrode setup in [20]. The equivalent circuit of a
pair of adjacent fingers in an IDE sensor with a solution that behaves similar to blood is
given by Figure 2. The term Rsol represents the solution resistance which is in series with
Cdl which represents the capacitive double layer, and Cgeo represents geometric
capacitance between fingers. In an analysis more specific to whole blood Rsol might be
replaced with multiple resistors and capacitors to represent physical characteristics of
blood.

Figure 2. Equivalent circuit model of a solution without redox ions in an IDE sensor.
The total impedance of the circuit in Figure 2 is given by Equation 7. Current studies
using the IDE method [7, 8] have focused on impedance analysis with the equivalent
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circuit and have not used permittivity values.
ZIDE =

2
Rsol Cdl
Cgeo + Cdl + Cgeo (ωRsol Cgeo Cdl )2
+
j
(Cgeo + Cdl )2 + (ωRsol Cgeo Cdl )2
ω[(Cgeo + Cdl )2 + (ωRsol Cgeo Cdl )2 ]
Equation 7

Analysis of Figure 2 leads to the desire to choose a frequency where current will pass
through Rsol while minimizing contributions from Cdl . Alternatively, the Cgeo path can be
used if measurements are compared between air and the material in question.

7

CHAPTER TWO: LITERATURE REVIEW
2.1 Biological Applications of Impedance Spectroscopy
Impedance spectroscopy of biological samples is a powerful technique with broad
applications across multiple fields. A review by Lisdat et al. discusses the general use of
impedance spectroscopy for biosensing applications [19]. Impedance spectroscopy can
detect changes occurring near the electrode surfaces or in the bulk solution. It provides a
means of label-free detection, avoiding the complication of modifying biomolecules with
markers. Two general approaches to bioimpedance sensing are described. In the first, the
solution conductivity is measured against time or solution concentration changes. This
approach requires minimizing the impedance of the electrode-solution interface, which
can be achieved by using large surface area electrodes and choosing an electrode material
that will not interact with the biological material. The second approach involves binding
biomolecules to electrodes and measuring changes in charge transfer resistance (if
redox-active compounds are present) or capacitance (if a blocking layer on the electrode is
used) as molecular interactions take place on the electrode surface. The counter electrode
impedance must be much less than the sensing electrode impedance, which can be done
by controlling the surface areas of each electrode relative to the other. Examples of
detecting analytes, antibodies, nucleic acid, enzymes, and cells are discussed. Strategies
for increasing electrode sensitivity are discussed which include the use of IDEs for
detecting changes near the electrode surface, decreasing distance between electrodes to
enhance electric field strength.
Sun et al. developed a biosensor to measure epithelial barrier function by observing
impedance changes in the cells’ reaction with other chemicals [21]. Their goal was to
better monitor tissue in the throat. A conductive polymer layer was added on top of the
electrodes to increase the electrode surface area, reducing CDL effects and extending the
sensor’s low frequency sensitivity. The addition of the polymer layer reduced the
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impedance and capacitive response of the electrodes. A finite element model was used to
aid in developing an equivalent circuit model for their setup. Their impedance
spectroscopy results compared favorably to an existing diagnostic technique.
Impedance changes have also been used to study the porosity of biomaterials, such as
in the study by Tully-Dartez et al. [22]. The calculated porosity from impedance
measurements was compared to scanning electron microscopy (SEM) and mercury
intrusion porosimetry (MIP) measurements with favorable results, and had the advantage
of impedance spectroscopy being a nondestructive test. Another study [23] used
impedance measurements to estimate bone porosity. In another study simulations of
electrical measurements of cell growth on a substrate were performed and it was found
that porous substrates had better performance than nonporous substrates [24]. Neagu et al.
used impedance spectroscopy on porous collagen and nonporous gelatin samples and
attempted to correlate measurements with microsctructural properties observed by SEM
[25].
Park et al. used impedance spectroscopy to correlate changes in blood glucose with the
dielectric constant of blood [26]. These studies demonstrate the versatility of impedance
measurements in investigating various physical phenomena in biological samples.
2.2

Electrode Characterization and Design
Rana et al. characterized the frequency response of IDEs for electrochemical sensing

applications in [20], proposing an equivalent circuit model and showing the effects of the
CDL, solution resistance, and sensor geometry capacitance. The IDE performance is
compared to a pair of needle probes. They identify three distinct regions, the low
frequency region dominated by the CDL, the mid frequency region dominated by solution
resistance, and the high frequency region dominated by geometric capacitance. These
regions define the limits of sensitivity for an IDE sensor. Depending on the experiment,
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changes in the solution resistance or geometric sensor capacitance may be of interest and
recommendations are made for each case. Understanding how the phenomena one wishes
to observe fit in with these regions is essential for designing an effective experiment.
Sensor design is further explored by Hong et al. in a study in which co-planar
electrode parameters were varied and frequency response was recorded [27]. They had the
same equivalent circuit model as [20] and defined three frequency regions with the same
parameters. They observed that increasing solution conductivity increased the cutoff
frequencies of each region. Increasing interelectrode spacing did not change frequency
region width but shifted cutoff frequencies lower and raised impedance values. Increasing
electrode area decreased the low frequency cutoff only.
Chen et al. developed an analytical model for coplanar IDEs targeted for sensing
changes in liquid droplets [28]. They proceeded to design a sensor with varying electrode
widths to better measure nonuniform height of liquid droplets. Equations for calculating
the capacitance of a single electrode digit pair and the relevant physical electrode
parameters are given. It is found that reducing electrode gap spacing while choosing
electrode width similar to the expected drop thickness results in the maximum capacitive
signal.
A set of equations for calculating the capacitance of an IDE structure with an arbitrary
number of substrates including fringe effects of the end electrode fingers is presented in
[29, 30]. These results can be used for sensor design or comparison to experimental
techniques to determine a sensor’s base capacitance when calibrating an experimental
setup.
A study by Bragos et al. compared the use of two and four electrode setups for
monitoring cell growth with impedance spectroscopy [31]. They describe factors affecting
the two electrode setup including sensitivity to surface area covered or exposed and
difficulty detecting changes above the first layer of cells (sensor penetration depth). They
10

found a four electrode setup was more sensitive to density of the biological samples.
In a work by Olmo et al., a model of an electrode biosensor is constructed and
analyzed using finite element analysis [32]. Their model includes the effects of the cell
membrane and cell-electrode gap. This study focused on changes due to cell growth but
the model can be adapted for other bio-impedance experiments. The ability to model
electrode structures accurately can help speed up and reduce the cost of experiment
design.
2.3

Electrical Characterization of Blood
Research focused on measuring the impedance of blood has had mixed results. Zhao

et al., found a correlation between fibrinogen levels and erythrocyte sedimentation rate
(ESR) in human blood by measuring impedance at three different frequencies [14].
Impedance was observed to increase with fibrinogen concentration. They developed a
simple circuit model for blood and determined the circuit parameters from experimental
data. Blood was modeled as plasma resistance in parallel with the series combination of
cell interior resistance and membrane capacitance. They proposed RBC aggregation and
interfacial polarization as causes for the observed changes in impedance with variation of
fibrinogen concentration. Blood cells have a net negative charge but interaction with
positively charged plasma proteins like fibrinogen neutralizes the RBCs allowing rouleaux
formation.
Pop et al., found a correlation between whole blood capacitance and viscosity which
matches hematocrit (Ht) and fibrinogen changes [13]. Only a weak correlation between
plasma resistivity and fibrinogen and Ht was observed. These results indicate that
electrical measurement of blood impedance can be used to determine blood viscosity
which is associated with inflammation. Both [13] and [14] only measured blood
impedance at three frequencies and did not discuss the experimental setup of their
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electrodes or parasitic effects, making it difficult to determine what physical phenomena
may have influenced their measurements.
In [8] Ramaswamy et al., developed a microfluidic sensor using a pair of IDEs to
perform impedance measurements and correlate changes in impedance with clotting time.
They observed an initial increase in impedance as clotting begins, a peak when clotting
has finished, and a decrease in impedance after clotting has finished. Across multiple tests
there were large differences in impedance magnitude and phase but coagulation time
values were consistent. They found the optimum frequency for their device to be around 6
kHz and cite differences in blood conditions and electrode configurations as possible
reasons for why it is different from the 1 MHz region found by other researchers such as
[5]. However, they only scanned from 10Hz-100kHz, other researchers [15, 33] have
identified CDL as being the dominant factor in this low frequency region which the
authors of [8] did not address, and that could help explain the large variation in magnitude
observed in [8] as well.
Another study using planar electrodes and low frequency signals (1kHz-100KHz)
observed an impedance peak, but found a change in slop after the peak correlated best
with blood clotting times [34]. A slope change did not appear in non-clotting blood
samples and varying amounts of heparin added to the blood extended the clotting time and
slope change accordingly.
Lei et al., used planar electrodes in a microfluidic well to measure the impedance of
blood samples while varying temperature and Ht levels [7]. The blood clotting time was
determined by a change in impedance magnitude. The fabrication of their sensor along
with a circuit model including CDL effects were presented. Similar to [8, 34] they used
impedance measurements in the low kHz region. Interestingly, they did not observe an
impedance peak followed by a drop as was observed in the other studies, instead
impedance increased and fluctuated around the higher level.
12

Baskurt et al., performed a detailed study on blood cell aggregation measuring
impedance changes and found that impedance data sometimes failed to correlate with
aggregation changes, but extracting the capacitance values from the impedance data
provided excellent results [35]. Baskurt was measuring reversible blood cell aggregation
as opposed to clotting times measured by other researchers [8, 34, 7] but did observe a
peak followed by a decrease when looking at capacitance data, while impedance data
showed a peak with a very minor decrease closer to what was observed in [7] but with less
fluctuations. It should be noted that the setup in [35] is unique, they used a glass tube with
electrodes on either end, so geometry effects would be quite different.
With the availability of better test equipment enabling rapid, broad spectrum
frequency measurements and recognition of the short-comings of impedance data, recent
research on electrical measurement of blood coagulation has begun to favor dielectric
measurements derived from impedance measurements [5, 11, 15].
Asakura et al., investigated changes in relative permittivity during thrombus formation
and found that the real part of permittivity increased during RBC aggregation and
thrombus formation [36]. They analyzed their results with an equivalent circuit model
similar to previous studies including plasma resistance, cell membrane capacitance, and
cell interior resistnace, along with CDL and parasitic electrode effects. They also tested
samples without RBCs to determine the effects of fibrinogen and Ht levels, observing that
these generally decreased permittivity, so the increases observed during clotting must be
due to RBC aggregation.
A study by Fuse et al., looked at the correlation between blood permittivity and blood
clot formation while varying blood volume [11]. They observed a linear relationship
between the Ht level for a fixed volume with permittivity increasing with Ht. They
observed a similar relationship for increasing the volume of blood used to form the clot.
However, this relationship only existed over a range of 100-600 KHz. They note that the
13

exact frequency range may depend on sensor geometry and other factors.
Maji et al., have done extensive research on characterizing the blood clotting process
and developed a microfluidic sensor which measures clotting time and platelet activity via
dielectric permittivity [12, 15, 16]. They propose a circuit model for whole blood within a
microfluidic sensor setup match experimental data to simulated data. They focus on
modeling the CDL effect and identifying the dispersion region of whole blood which is
most sensitive to changes in RBC aggregation. They propose a double Debye relaxation to
model permittivity and found it produced a closer match to experimental data than the
common Cole-Cole model. They also concluded that the imaginary part of dielectric
permittivity was not strongly affected by changes to RBCs and therefore the focus should
be on the real part of dielectric permittivity. Their design uses a parallel plate electrode
structure embedded in a microfluidic channel. They found the real part of blood’s
dielectric permittivity to be most sensitive to the changes occurring during clotting in the
hundreds of kHz to tens of MHz range due to interfacial polarization between RBCs. The
frequency of 1 MHz was found to be the most sensitive overall. They detail the fabrication
of their sensor, calibration, and compared their sensor’s performance to rotational
thromboelastometry (ROTEM), a whole blood assay currently used in clinical settings for
analyzing coagulation time and clot strength. They found the time to peak permittivity in
their sensor correlated well with ROTEM clotting time and the maximum change in
permittivity correlated well with ROTEM maximum clot firmness.
Hayashi et al., coin the term dielectric coagulometry in their study of blood
permittivity to characterize clotting [5]. They tested both animal and human blood and
found the permittivity to be most sensitive around 1 MHz. They observe an initial increase
followed by a peak and decrease in the permittivity. They use the hanai mixture formula to
model permittivity of blood propose several models to explain the changes in permittivity
by relating them to sedimentation rate of RBCs.
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In a follow up study by Hayashi et al., they continue to characterize clotting with
permittivity measurements and expand on their connecting the observed electric
phenomena with the blood clotting process [33]. They identify three key phases of blood
clotting, rouleau formation, erythrocyte aggregation and fibrin formation, and erythrocyte
transformation with fibrin stabilization. They use cole-cole analysis to study the dielectric
relaxation observed in the permittivity which aligns with peak clotting time.
There is more consistency in the results of studies using dielectric permittivity as a
means to measure RBC aggreagation and measure clotting time [11, 15, 33, 36]. Another
commonality between these studies is the use of a parallel electrode setup.
Huu et al., found that relaxation frequency, fc , derived from Cole-Cole analysis of
blood impedance measurements correlated well with blood clotting time [37]. They
observed fc to have an initial increase, peak, and then decrease. The initial increase is
believed to be due to the permittivity increase as clotting factors are activated, the peak
and subsequent decrease are believed to be due to RBC aggregation. They used Hanai’s
mixture formula to model the complex permittivity of blood and two models of RBC
aggregation representing the increase and decrease of fc to create a simulation which
helped explain their experimental results.
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CHAPTER THREE: RESEARCH OBJECTIVES
The overall goals of this work were to investigate the electrical properties of blood and
blood clots and to explore further uses of impedance spectroscopy to detect and measure
clinically meaningful changes in blood. These goals were accomplished through the
following objectives.
First, an effective test fixture was developed. As discussed previously, researchers have
used a variety of different test setups, but often end up developing a custom sensor and
microfluidic platform. This can create difficulty in reproducing results. In this research no
custom fabrication was used; all parts of the test setup are commercially available. This
easily allows anyone to recreate the experiment. Characterization of the electrode, test
fixture, and impedance analyzer as an entire setup was included in this development.
The second objective was to obtain the impedance spectroscopy of clotting and
non-clotting blood. For dielectric spectroscopy to be a useful technique there must exist
clear measurable differences between clotting and non-clotting blood. Qualitative and
quantitative profiles of each condition were developed with the aid of circuit models and
numerical methods to fully interpret the results.
To better understand what can be effectively measured with impedance spectroscopy it
was also the goal of this work to measure separately the contributions of PRP and RBCs.
PRP plays a greater functional role in the clotting process but as previously discussed
literature indicates DS is most sensitive to RBCs. The results of these experiments helped
guide later experiments and may guide future research as well.
The last objective was to obtain the impedance spectroscopy of blood clots under
physiologically relevant conditions. To this end, the test setup designed in the first
objective was used to obtain the impedance spectroscopy of blood clots induced by the
extrinsic pathway (TF), platelet activation (TRAP-6, ADP) and the addition of thrombin.
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CHAPTER FOUR: MATERIALS AND METHODS
Blood samples used in this research were acquired from volunteer donors after
receiving informed consent (IRB #F16134). Blood was drawn by phlebotomists at the
SJSU Student Health Center and collected in citrated tubes to prevent spontaneous
coagulation during transport and experiment preparation. All experiments were conducted
with fresh blood within four hours of drawing.
Commercially available IDEs composed of 10 µm gold electrode fingers with 10µm
spacing between fingers on a glass substrate (Micrux) and a microfluidic all-in-one
platform with batch cell add-on (Micrux) were used to hold samples during measurement.
The microfluidic platform was connected to an E4990A Impedance Analyzer (keysight)
using alligator clips and the 16048G accessory. Test fixture compensation was performed
according to the E4990A manual. During some tests two microfluidic platforms were
multiplexed to the analyzer using a relay (Kemet) controlled by a microcontroller
(Arduino Leonardo) receiving input from an I/O connector on the E4990A. The E4990A
measurements were automated using Keysight Command Expert software.
Experiments were performed at approximately 37 degrees Celsius by placing the
microfluidic platform on top of a temperature controlled base and covering it with a
temperature controlled lid (Ibidi). Before adding any reagents, blood samples were placed
in an eppendorf tube in the temperature-controlled fixture and warmed for five minutes.
After adding any reagents (processes described below), the samples were manually
mixed with a pipette and 100 µL was then deposited into the microfluidic fixture.
Automated impedance measurements were immediately started and continued to be taken
every 30 seconds for up to 45 minutes.
After completing an experiment, the test fixture was cleaned with kim wipes and 70%
ethanol. Electrodes were cleaned, inspected, and reused if no damage was found.
All experiments were performed in at least duplicate on the same day with the same
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blood and repeated again in duplicate with another donor on a different day.
Data analysis was conducted with Excel, Python 3.6, and the Spyder integrated
development environment for Python. Several Python libraries were used, most notably
Pandas and MatPlotLib. Statistical analysis was done in python as well using the
statsmodels package to perform one way analysis of variance (ANOVA) and post-hoc
Tukey’s tests in which a P value less than 0.05 was considered statistically significant.
The impedance data were converted into permittivity normalized to the initial
permittivity measurement using Equation 8, where imag(Z) represents the imaginary part
of the measured impedance, C0 represents the average permittivity of the fixture with air
as the dielectric, and t=0 is the initial permittivity measurement.
N ormalizedP ermittivity(t = 0) = n,t=0 =

imag(Z)−1
C0 t=0

Equation 8

For electrode characterization, potassium chloride (Fisher Chemical) was used
mixed with DI water to form solutions of varying concentration. To induce clotting, 1 M
calcium chloride (Fisher Chemical) was added to blood samples to achieve a final
concentration of 0.2 M. To separate RBCs and PRP for isolated study some samples of
blood were centrifuged for 20 minutes at 250 RCF. The plasma was then removed to a
separate container using a pipette. Then the RBCs were mixed with phosphate buffered
saline (PBS) so the sample returned to its original volume. Recombinant tissue factor
(Haematologic Technologies, Inc.) was added to accelerate clotting in some tests,
obtaining a final concentration of 3 ng/mL. The blood was also treated with calcium
chloride. TRAP-6 (TOCRIS) was also used to accelerate clotting by mixing 8.62 µL with
300 µL of whole blood treated with calcium chloride. Adenosine 5’-diphosphate (ADP)
(BioData Corporation) was used to activate platelets in samples with a final concentration
of 20 µM. ADP was added to whole blood which was treated with calcium chloride as
described above. Thrombin was added to some samples to induce faster clotting. A
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volume of 1.5 µL was added to 300 µL of citrated whole blood which had been treated
with calcium chloride as described above. In some tests, a volume of 1.0 µL of thrombin
was used. Those runs are labeled accordingly.
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CHAPTER FIVE: SAFETY
Working with blood carries some inherent risk as there are diseases that can be
transferred from contact with infected blood. To prevent any transmission of disease,
clothing including gloves, long sleeves, and long pants were worn at all times to minimize
areas of open skin. Open containers of blood and related products (plasma etc) were
handled inside a biohood whenever possible. All blood-contaminated products were
disposed of in clearly labeled biohazard waste containers. Any spills were cleaned with
disinfectant (70% ethanol) and paper towels.
When analyzing data and working for extended periods of time on a computer, proper
posture and ergonomics were considered, including appropriate height of desk and chair.
Short breaks were taken every hour to prevent eye strain.
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CHAPTER SIX: RESULTS AND DISCUSSION
6.1

Electrode Characterization
Initial experiments sought to explore the behavior of liquids with known

characteristics so that the test fixture could be characterized and provide reference points
for later calculations.
Figure 3 shows the impedance response (left) and phase response (right) for the test
setup with air, DI water, and a conductive solution (potassium-chloride). In the case of air,
only the geometric capacitance path is present (Figure 2), which makes sense as the
fingers of the IDE serve as the conductive plates of a capacitor with air as the dielectric.
The phase is a constant -90 degrees and impedance decreases with frequency as expected
in a capacitor. The phase response for water is initially approaching zero, indicating a shift
from capacitive to resistive response, and then it decreases toward -90 degrees, indicating
a return to a capacitive response. This behavior also matches well with the model in
Figure 2, where initial behavior at low frequencies is capacitive and resistive due to the
CDL and conductivity of the sample, but as frequency increases the geometric capacitance
begins to dominate the response. Note that at high frequencies, water is parallel to air and
does not intersect the air line, indicating that the geometric capacitance value has changed
because water has replaced air as the dielectric. The potassium-chloride solutions have an
extended resistive region compared to water, and a lower impedance as expected due to
the increased conductivity. Extrapolating a bit, it looks like at higher frequencies the
potassium-chloride solution would be close to that of water, indicating a very small
change in dielectric behavior. This is because the potassium-chloride ions influence the
conductivity of the solution but don’t provide new means of storing charge in the liquid.
Figure 3 shows the electrode response at a single moment in time across a wide range of
frequencies. Before moving on to experiments with blood which was expected to change
over time, water was used as a liquid that should be stable over time to validate the test
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Figure 3. Bode plot showing impedance and phase response for air, DI water, and
potassium-chloride of different concentrations.
setup and environmental conditions. Comparing initial measurements with those later in
time revealed some variation over time when it was expected that water samples would
remain constant, shown in Figure 4. This was attributed to evaporation, and it was visually
observed that small sample volumes would completely evaporate from the test fixture if
left sitting long enough. It was interesting to note the frequency dependence of the
variation. The largest change was in the hundreds of kilohertz where water is most
resistive, while the variation approaches zero past 1 MHz where the geometric capacitance
is dominant. This suggests that sample volume influences the conductivity more so than
the geometric capacitance, perhaps because the electric field falls with the square of
distance and so the most charge and most sensitivity would occur closest to the electrodes.
This also suggests that minimizing sample volume is advantageous for two reasons,
reducing waste of materials and more importantly keeping the majority of the sample
close to the electrodes so that changes will influence the geometric capacitance in addition
to the conductivity.

22

Figure 4. Top: Bode plot showing measurements of a water sample 15 minutes apart.
Bottom: A graph showing the percentage change in impedance against frequency.
A series of experiments was carried out to determine the optimum sample volume and
test fixture that would provide the most stable measurements over time and minimize
variation in measurements due to evaporation. The results are presented in Table 1. The
best performance was observed with the well fixture, even at higher temperatures. Larger
sample volumes are only possible with the well fixture, and 100 µL was found to be an
optimal value minimizing impedance variation across the frequency spectrum while
minimizing sample volume. Although a higher temperature may technically increase the
evaporation rate, it was found that the higher temperature was required for clotting to
occur as will be further explained in the following sections.
6.2

Experiments with Whole Blood
After characterizing the electrode response, experiments focusing on samples of

citrated whole blood were performed to determine the behavior of blood in the absence of
clotting. As seen in Figure 5 the normalized relative permittivity of non-clotting whole
blood showed an increase at high frequencies during the first five minutes, after which the
rate of increase slowed considerably and normalized relative permittivity settles to a
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Table 1. Conditions and Range of Variation in the Impedance of Water
Volume (µL)
10
20
10
20
100
200
300
400

Setup
open
open
3d printed cover
well fixture
well fixture
well fixture
well fixture
well fixture

Temperature (C)
22
22
37
37
37
37
37
37

Time (min)
10
10
15
15
15
15
15
15

Impedance Variation (%)
0 - 50
0 - 35
0 - 75
0 - 35
-18 - 20
0 - 25
-20 - 20
-10 - 20

maximum. This change was due to the natural separation of RBCs and plasma which
occurs in static blood samples and will be further discussed in the following section. In
the middle frequency range a trough following a similar but inverted pattern appears. This
trough was observed by other researchers as well [5, 15] but the magnitude of the response
was less than that at higher frequencies so the higher frequency phenomena is favored for
analysis. Frequencies below 100 kHz showed no change due to the CDL and solution
resistance current paths being dominant at lower frequencies [12, 20].
To better understand the sedimentation effect’s influence on permittivity response a
sample of citrated whole blood was manually mixed with a pipette every 10 minutes. In
Figure 6 the permittivity increase in citrated whole blood is shown to be reversible when
manually mixing the blood with a pipette. Similar results have been reported in literature
[33].
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Figure 5. Changes in normalized permittivity for non-clotting whole blood. This figure is
representative of one experiment performed in duplicate with five donors on five different
days.

Figure 6. Reversibility of sedimentation effect is shown by mixing at 10 minute intervals.
This figure is representative of one experiment performed in duplicate with five donors on
five different days.
Figure 7 shows the permittivity change versus frequency at different times during the
mixing experiment. At low frequencies mixing had no effect on permittivity but at high
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frequencies a large change was seen immediately after mixing. This indicated that the
high frequency measurements are sensitive to the distribution of RBCs in the sample. It
was further shown by Figure 7 that permittivity returns to the same minimum value after
approximately 5 minutes, thus the sedimentation effect is reversible and repeatable. Part
of the increase is associated with rouleaux formation [33] but in our IDE setup part of the
response may also be due to the change in density of RBCs close to the surface of the
sensor. As the primary charge storage mechanism between RBCs is their interfacial
polarization, anything that decreases the space between RBCs should result in an increase
in measured relative permittivity.

Figure 7. Normalized real permittivity returns to a minimum after about five minutes. This
figure is representative of one experiment performed in duplicate with five donors on five
different days.
The next experiments examined the roles which platelet rich plasma (PRP) and RBCs
play separately in the permittivity measurements and the results are shown in Figure 8.
For PRP, visually a gel was observed to form in the test fixture, but Figure 8 shows that
impedance spectroscopy is not sensitive to changes in PRP. The PRP samples did not
exhibit any sedimentation effect or change corresponding to changes in PRP viscosity.
This finding is in agreement with other research [15, 33] which concludes that the main
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electrical response in blood is due to interfacial polarization of RBCs.

Figure 8. PRP shows no response across the measured frequency spectrum, while RBCs
in PBS show a settling behavior similar to whole blood. This figure is representative of one
experiment performed in duplicate with three donors on three different days.
Figure 8 shows the response of RBCs in a PBS solution has a similar but muted
response compared to whole blood. This indicates DS is sensitive to changes in RBC
formation. While changes in PRP are not directly measurable, the difference between
RBCs in PBS and whole blood indicates their influence on RBCs contributes to the overall
measured change in whole blood when clotting occurs.
6.3

Effects of Agonists on Clotting
After establishing RBCs as the primary marker of DS and identifying the response of

citrated blood, experiments using agonists to induce and accelerate clotting were
performed. First calcium-chloride was used to restore calcium to the citrated blood and
initiate clotting. Multiple test setups and sample volumes were tested before identifying
optimal conditions.
Figure 9 shows the test setup and Figure 10 is a comparison of citrated and recalcified
blood using 10 µL drops on the open face of the IDE. By the end of 20 minutes both
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samples had lost significant volume due to evaporation making it difficult to determine if
clotting had occurred, thus any difference cannot be confidently attributed to clotting.

Figure 9. A 10 µL blood sample on the open air electrode fixture.
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Figure 10. Changes in normalized permittivity for citrated and recalcified blood using
open electrode fixture and 10 µL samples. This figure is representative of one experiment
performed in duplicate with three donors on three different days.
A rectangle with one open face was fabricated with a 3-D printer to act as a cover for
the 10 µL drops on the open electrode face with the goal of reducing evaporation effects,
shown in Figure 11. However, Figure 12 shows no clear difference between the response
of citrated and recalcified blood and reduction in sample volumes was still observed. In
addition there were difficulties in consistent placement of the sample on the electrode and
placement of the 3-D printed cap which may contribute to inconsistent results.
Figure 13 shows 100 µL samples in the well fixture at room temperature had
consistent behavior and evaporation did not appear to be an issue but clotting was not
observed in a timely manner. Going forward the temperature was raised to 37 C to more
closely mimic the conditions in the human body.
Figure 14 shows the response of whole blood when calcium-chloride is added to
induce clotting. The normalized permittivity at high frequencies shows an increase around
20 minutes which correlates with clotting visually observed in the sample and agrees with
results in literature [33]. The changes in permittivity in blood were credited to interfacial
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Figure 11. Image of the open electrode sensor and white cap to cover it made with a 3D
printer.

Figure 12. Changes in normalized permittivity for citrated and recalcified blood using 3D
cap to cover 10 µL samples to limit evaporation effects. This figure is representative of one
experiment performed in duplicate with three donors on three different days.
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Figure 13. Changes in normalized permittivity for citrated and recalcified blood in the well
fixture using 100 µL samples. This figure is representative of one experiment performed in
duplicate with three donors on three different days.
polarization of RBCs suspended in conducting plasma [12]. As sedimentation occurs an
increase in permittivity is observed, however during clotting RBCs begin to group
together differently and the blood thickens causing a drop in permittivity.
In Figure 15 four plots show the changes in permittivity at different frequencies. A
clear trend between clotting and non-clotting samples was most clearly observed in the 1
MHz plot. At 10 kHz no changes were observed, due to the CDL as previously noted. At
100 kHz changes in slope for the clotting samples can be seen, but these changes occur
over a small range. At 10 MHz behavior was similar to that of 100kHz. Based on these
observations and similar observations in literature [33, 15], 1 MHz was chosen as the best
frequency to identify changes in blood due to clotting.
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Figure 14. Changes in normalized permittivity for clotting whole blood. This figure is
representative of one experiment performed in duplicate with five donors on five different
days.

Figure 15. A survey across frequencies clotting and non-clotting samples. This figure is
representative of one experiment performed in duplicate with five donors on five different
days.
Qualitatively clotting can be recognized as the decrease in permittivity, but other parts
of the clotting process can also be more easily identified by taking the derivatives as
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shown in Figure 16. Figure 16 shows four key phases of clotting at their respective times.
Ts marks the sedimentation time which corresponds with the derivative reaching zero, this
is primarily of interest in samples that do not have clotting. Ti indicates when the
derivative becomes negative and can be considered clot initiation where the effects of
clotting overtake the effects of sedimentation. In clotting samples Ti tends to follow Ts
very closely, so further discussion is mostly focused on Ti . Tp is the time at which the
derivative reaches a minimum at this point the clot can be considered to have polymerized.
Tc is the point at which the relative permittivity reaches within 10% of its final value and
clotting can be considered complete.

Figure 16. Top: Change in relative permittivity. Bottom: Derivative of change in relative
permittivity. Key points in the clotting process are labeled. This figure is representative of
one experiment performed in duplicate with five donors on five different days.
Figure 17 Thrombin, ADP, TRAP-6, and TF all decrease clotting time (min values of
derivative graph) relative to their role in the clotting cascade. Tissue factor (TF) is a
membrane protein mostly found in adventitial cells around blood vessels, epithelial layers
around organs, and some layers of the skin [6]. TF is the protein which initiates the
extrinsic clotting pathway. Figure 17 shows the minimum of the derivative for blood
treated with TF and calcium-chloride occurred around 14 minutes.
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Figure 17. Four agonists are compared. Top: Change in relative permittivity. Bottom:
Derivative of change in relative permittivity. This figure is representative of one experiment
performed in duplicate with five donors on five different days.
Thrombin receptor activated peptide (TRAP-6) has been found to increase platelet
aggregation and hyperactivity [38] and has been compared to Adenosine 5’-diphosphate
(ADP) when studying coagulation [39]. TRAP-6’s mechanism for platelet activation is
different than ADP, so it was of interest to test with both. The decrease in clotting time
using TRAP-6 and calcium-chloride is most clearly shown by the minimum derivative
point in Figure 17 which occurs just before TF’s around 13 minutes.
Platelet activation was achieved by adding ADP to whole blood treated with calcium
chloride. ADP is known to influence platelet shape change, cellular calcium use, platelet
aggregation, adhesion of platelets to thrombus, and other factors during coagulation
[40, 41]. The goal of the use of ADP in this experiment was to speed up the clotting
process and show that the DS technique and permittivity measurements are sensitive to
blood with increased platelet activation.
The decreased clotting time is reflected in Figure 17 where a minimum in the
derivative of normalized real relative permittivity change occurs around 10 minutes for

34

ADP, significantly faster than whole blood treated with calcium chloride. The ADP
samples are seen to have a peak derivative change around 0.02, similar to that of clotting
whole blood.
In the blood clotting process thrombin plays a major role in converting fibrin to
fibrinogen and also activates platelets [6]. The addition of thrombin to a blood sample
rapidly induces clotting, as was observed in Figure 17. The blood samples treated with
thrombin showed a very brief increase followed by a rapid decrease in permittivity which
quickly settled to a constant value.The derivative plot for thrombin in Figure 17 shows that
adding thrombin results in clotting times under five minutes.
The following discussion focuses on identifying trends and differences between the
different agonists by examining some of the key parameters in the data. All tests were
performed with five donors in duplicate for each donor. Figure 18, Figure 19, Figure 20,
Figure 21, Figure 22, and Figure 23 all show mean values with error bars to represent the
standard error of mean (SEM).
In Figure 18 the mean clot initialization times are shown for the four agonists as well
as recalcified blood. Using recalcified blood as the control all agonists had P values less
than 0.05. Thrombin had the shortest initialization time, about 1.5 minutes and was very
consistent. The platelet activators ADP and TRAP-6 both had average initialization times
under 10 minutes, but TRAP-6 had more variation. TF had an average initialization time
around 12 minutes and recalcified blood around 17 minutes. These times correlate well
with the role each agonist plays in the clotting cascade.
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Figure 18. Mean value of Ti with SEM bars from five different donors on five different
days.
The Tp times in Figure 19 represent clot polymerization and the times follow a similar
pattern to Ti with shorter times the further along the clotting process each agonist is.
However, statistical analysis differed, showing no significant difference between tissue
factor and recalcified blood. Other agonists still had P values less than 0.05.
Figure 20 shows the mean values for Tc which again follow the trend of shorter times
for agonists further into the clotting process. One difference that stood out was that
thrombin had a much wider variation than for the previous measures. This was a reflection
of how fast the changes occur in thrombin samples, because Tc was calculated as a percent
change from the final value but thrombin being a more dramatic process took a longer
time to settle. Statistically the results were equivalent to those for Ti .

36

Figure 19. Mean value of Tp with SEM bars from five different donors on five different
days.

Figure 20. Mean value of Tc with SEM bars from five different donors on five different
days.
The mean value of the minimum of the derivative of relative permittivity shown in
Figure 21 was an interesting parameter because it did not follow the same pattern as the
time based measurements discussed previously. Instead, all clotting processes seemed to

37

have fairly similar minimums between -0.01 and -0.02, except for TRAP-6 which was
about -0.03. This is reflected in statistical analysis as well with P values greater than 0.05
for all agonists except TRAP-6. The magnitude of the minimum derivative should reflect
how fast polymerization was occurring and it was surprising that TRAP-6 shows a
significantly larger magnitude here.

Figure 21. Mean value of minimum of derivative of relative permittivity with SEM bars
from five different donors on five different days.
Figure 22 combined with Figure 21 exposes a different pattern in the agonists.
Figure 22 shows the amount of time between clot initialization and clot polymerization
and it is interesting how this pattern differed from the trend followed for observing Ti , Tp ,
and Tc individually. Thrombin still had a very short time but the next shortest was
TRAP-6 which also had the greatest minimum slope. Also interesting is that TF spends
the longest time in this phase even though it’s overall clotting time is consistently faster
than recalcified blood. Further study of these time spans could allow DS to identify
abnormalities in a particular part of the clotting cascade or perhaps whether clotting is
being driven by the extrinsic or intrinsic pathway.
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Figure 22. Mean value of Tp −Ti with SEM bars from five different donors on five different
days.
Figure 23 shows the mean final values of the derivatives for each agonist. While there
is a wider variation, looking at the magnitude of the y-axis all values were quite close to
zero indicating that clotting activity was complete. What is most interesting is that
thrombin has a positive value. This is most likely because clotting finishes so fast that
sedimentation effects are starting to overtake clotting effects by the end of the experiment.
By identifying multiple time points which correspond to different events in the
clotting process, DS has the potential to give care providers a more detailed view of the
clotting process. Further work to develop profiles of healthy and abnormal clotting
behavior that can take into account the amount of time in each phase as well as measures
of clotting activity such as the minimum derivative and final derivative values may reveal
useful insights or provide diagnostic information.
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Figure 23. Mean value of the final value of the derivative of relative permittivity with SEM
bars from five different donors on five different days.
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CHAPTER SEVEN: CONCLUSION
A test setup using DS and IDEs to measure changes in permittivity in blood was
developed. Initially, the electrode setup was characterized with air, water, and
potassium-chloride solutions and compared to published results and models. After
understanding the different frequency regions characterized by the CDL, resistive, and
capacitive regions experiments were performed that focused on monitoring water over
time. Changes in the impedance of water over time were attributed to evaporation and the
test setup was adjusted to minimize evaporation effects and sample volume.
In this work, clotting and non-clotting blood were characterized by electrically
measured changes in permittivity. Non-clotting blood exhibited an increase in permittivity
at high frequencies associated with the sedimentation of RBCs in static blood. The
sedimentation was found to be reversible and repeatable by mixing samples.
Clotting was initially induced with the addition of calcium-chloride. The clotting
blood exhibited a decrease in permittivity at high frequencies that correlated with clotting
time. The increase was credited to the aggregation of RBCs as the blood clotted.
PRP and RBCs were also tested separately. It was found that PRP showed no change
in permittivity even when a change in viscosity was visually observed. RBCs were
observed to have a smaller response when suspended in PBS as compared to whole blood.
Thus, it is concluded that changes in plasma are not directly measurable and DS is only
measuring the aggregation of RBCs. However, the changes in plasma are indirectly
measured by their effect on RBC aggregation.
In addition, whole blood treated with TF, TRAP-6, ADP, and thrombin was studied
and it was confirmed that DS was able to detect the faster clotting times for each. Blood
treated with thrombin clotted the fastest, which is furthest along the clotting cascade,
while clotting times were longest for TF which is normally the catalyst for the start of the
extrinsic pathway. Multiple times were identified by taking the derivative of the
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permittivity curves to identify key phases of clotting including initiation, polymerization,
and completion.
Overall, the results of this study show DS is a promising technique for measuring
changes in coagulation in blood, but more study is needed. Future work should look to
connect research on the mechanical properties of blood clots with electrical sensing and
seek a correlation between electrical and mechanical measurements. In addition, further
research can be done to connect the key parameters identified with DS (e.g. Ti ) and the
amount of time between key times (e.g. Tp − Ti ) to more specific clotting processes and
look for differences between healthy and abnormal individuals or clinically relevant
conditions can be induced and studied such as manipulating blood to simulate trauma
conditions. Work can also be done to investigate clot strength and control for variations in
blood samples by fixing hematocrit levels.
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